1-20 of 54
Alan P. Skarbnik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: First Report of the Phase 1/2 Study of the Safety and Efficacy of CPO107, a Bispecific Agent Targeting CD20/CD47 in CD20 Expressing Non-Hodgkin Lymphoma (NHL)

Alan P. Skarbnik, Franklin L. Chen, Luke Mountjoy, Zaw Win Myint, Patricia A. Young, Andrew R. Whiteley, Steven Novick, Jennifer Su, Qingxi Wang, Kevin Romanko, Xi-De Wang, Yejia Li, Shulin Zhong, Liping Song, Ranjana H. Advani
Journal: Blood
Blood (2022) 140 (Supplement 1): 12059–12060.
DOI: https://doi.org/10.1182/blood-2022-164746
Published: 2022
Journal Articles

Subcutaneous Epcoritamab in Novel Combinations with Antineoplastic Agents Among Patients with B-Cell Non-Hodgkin Lymphoma in a Phase 1b/2, Multicenter, Open-Label Study: Assessing Safety, Tolerability, and Preliminary Efficacy (EPCORE NHL-5)

Laurie H. Sehn, Johannes Duell, Irit Avivi, Joshua Brody, Dok Hyun Yoon, Brian Elliot, Satya R. Siddani, Yang Bai, Apurvasena Parikh, Mostafa M. Seliem, Minh Dinh, Alan P. Skarbnik
Journal: Blood
Blood (2022) 140 (Supplement 1): 12108–12109.
DOI: https://doi.org/10.1182/blood-2022-157596
Published: 2022
Journal Articles

Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy

Clinical Trials & Observations
Anthony R. Mato, Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel, Ian W. Flinn, Jacqueline C. Barrientos, Kanti R. Rai, James A. Reeves, Bruce D. Cheson, Paul M. Barr, Suman Kambhampati, Frederick Lansigan, Jeffrey J. Pu, Alan P. Skarbnik, Lindsey Roeker, Gustavo A. Fonseca, Andrea Sitlinger, Issam S. Hamadeh, Colleen Dorsey, Nicole LaRatta, Hanna Weissbrot, Eline T. Luning Prak, Patricia Tsao, Dana Paskalis, Peter Sportelli, Hari P. Miskin, Michael S. Weiss, Jakub Svoboda, Danielle M. Brander
Journal: Blood
Blood (2021) 137 (20): 2817–2826.
DOI: https://doi.org/10.1182/blood.2020007376
Published: 2021
Includes: Supplemental data
Journal Articles

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Clinical Trials & Observations
Steven P. Treon, Jorge J. Castillo, Alan P. Skarbnik, Jacob D. Soumerai, Irene M. Ghobrial, Maria Luisa Guerrera, Kirsten Meid, Guang Yang
Journal: Blood
Blood (2020) 135 (21): 1912–1915.
DOI: https://doi.org/10.1182/blood.2020006288
Published: 2020
Journal Articles

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Clinical Trials & Observations
Ian W. Flinn, Peter Hillmen, Marco Montillo, Zsolt Nagy, Árpád Illés, Gabriel Etienne, Julio Delgado, Bryone J. Kuss, Constantine S. Tam, Zoltán Gasztonyi, Fritz Offner, Scott Lunin, Francesco Bosch, Matthew S. Davids, Nicole Lamanna, Ulrich Jaeger, Paolo Ghia, Florence Cymbalista, Craig A. Portell, Alan P. Skarbnik, Amanda F. Cashen, David T. Weaver, Virginia M. Kelly, Barry Turnbull, Stephan Stilgenbauer
Journal: Blood
Blood (2018) 132 (23): 2446–2455.
DOI: https://doi.org/10.1182/blood-2018-05-850461
Published: 2018
Includes: Supplemental data
Journal Articles

Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings

Lindsey E. Roeker, MD, Christopher P. Fox, MD PhD, Toby A. Eyre, John N. Allan, MD, Stephen J. Schuster, MD, Chadi Nabhan, MD, Brian T. Hill, MD PhD, Nirav N Shah, MD, Frederick Lansigan, MD, Maryam Yazdy, MD, Nicole Lamanna, MD, Bruce Cheson, MD, Arun K Singavi, MD, Catherine C. Coombs, MD, Paul Barr, MD, Alan P Skarbnik, MD, Mazyar Shadman, MD MPH, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Allison M. Winter, MD, Joanna Rhodes, MD, Colleen Dorsey, BSN, RN, Hannah Morse, BSN, John M. Pagel, MD PhD, Annalynn M Williams, MS, Ryan Jacobs, MD, Andre Goy, MD, Sivraj Muralikrishnan, MD, Laurie Pearson, MD, Andrea Sitlinger, MD, Neil Bailey, MSc, Anna Schuh, MD PhD, Danielle M. Brander, MD, Amy A Kirkwood, MSc, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4410.
DOI: https://doi.org/10.1182/blood-2018-99-118159
Published: 2018
Journal Articles

Comparison of Peripheral Blood Stem Cell Mobilization for Multiple Myeloma Patients over 70 Years of Age with Younger Patients

Ning Dong, MD, David S Siegel, MD PhD, Phyllis McKiernan, Noa Biran, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Andrew L. Pecora, MD, Scott D. Rowley, MD, Michele L. Donato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4554.
DOI: https://doi.org/10.1182/blood-2018-99-117498
Published: 2018
Journal Articles

Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study

Anthony R Mato, MD, Maryam Sarraf Yazdy, MD, Brian T. Hill, MD PhD, Mazyar Shadman, Hande Tuncer, MD, Allison M. Winter, MD, Kaitlin Kennard, RN, BSN, John N. Allan, MD, Chaitra S. Ujjani, MD, Danielle M. Brander, MD, Chadi Nabhan, MD, Paul Barr, MD, Jennifer R. Brown, MD PhD, Christopher P. Fox, MD PhD, Joanna Rhodes, MD, Anna Schuh, MD PhD, Toby A. Eyre, MD, Nicole Lamanna, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Alan P Skarbnik, MD, Lindsey E. Roeker, MD, Rajat Bannerji, MD PhD, Andrew M. Evens, MD, Frederick Lansigan, MD, Jennifer C. Samp, MS, PharmD, Jacqueline Nielsen, PhD, James M. Pauff, Thomas J. Kipps, MD PhD, Stephen J. Schuster, MD, George A Follows, MD PhD, Bruce Cheson, MD, Barbara Eichhorst
Journal: Blood
Blood (2018) 132 (Supplement 1): 4759.
DOI: https://doi.org/10.1182/blood-2018-99-119015
Published: 2018
Journal Articles

Evaluation of T Cell and Monocyte Immune Subsets in the Stem Cell Product of Patients Developing Engraftment Syndrome Following Autologous Stem Cell Transplantation for Multiple Myeloma and Lymphoma

Dante B. Descalzi-Montoya, PhD, Zheng Yang, MS, Kira Goldgirsh, MS, Rena Feinman, PhD, David S Siegel, MD PhD, Noa Biran, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Phyllis McKiernan, Melissa Baker, MSN, ANP, Michele L. Donato, MD, Robert Korngold, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4604.
DOI: https://doi.org/10.1182/blood-2018-99-120103
Published: 2018
Journal Articles

Prospective Analysis of Bortezomib, Fludarabine and Melphalan As Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation for Multiple Myeloma

Phyllis McKiernan, David S Siegel, MD PhD, David H. Vesole, MD PhD, Tracy Andrews, MSc, Noa Biran, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Jacquelyn Callahan, RN, Andrea Ortega, RN, Mariefel Vendivil, RN, Supreet Kaur, MD, Marshall McKenna, MD, Michele L. Donato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1020.
DOI: https://doi.org/10.1182/blood-2018-99-117313
Published: 2018
Journal Articles

Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma

Stacey L. Fanning, PhD, Kira Goldgirsh, MS, Dante B. Descalzi-Montoya, PhD, Rena Feinman, PhD, David S Siegel, MD PhD, Noa Biran, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Phyllis McKiernan, Melissa Baker, MSN, ANP, Michele L. Donato, MD, Robert Korngold, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2131.
DOI: https://doi.org/10.1182/blood-2018-99-118763
Published: 2018
Journal Articles

Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Noa Biran, MD, Shijia Zhang, MD PhD, Scott D. Rowley, MD, David H. Vesole, MD PhD, Michele L. Donato, MD, Alan P Skarbnik, MD, Joshua R Richter, MD, Andrew L. Pecora, MD, David S Siegel, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2154.
DOI: https://doi.org/10.1182/blood-2018-99-114832
Published: 2018
Journal Articles

Evaluation of Treg and Memory T Cell Profiles, Post-ASCT with Early Combination Nivolumab/Ipilimumab Therapy, in Patients with Multiple Myeloma (MM) and Diffuse Large B Cell Lymphoma (DLBCL)

Dante B. Descalzi-Montoya, PhD, Zheng Yang, MS, Kira Goldgirsh, MS, Rena Feinman, PhD, Stacey L. Fanning, PhD, David H. Vesole, MD PhD, Pashna N. Munshi, MD, Michael B Atkins, MD, Scott D. Rowley, MD, Noa Biran, MD, David S Siegel, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Michele L. Donato, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Robert Korngold, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3421.
DOI: https://doi.org/10.1182/blood-2018-99-120240
Published: 2018
Journal Articles

Largest Reported Series of Adults Who Received Treatment with Eculizumab (ECU) for Hematopoietic Cell Transplantation-Associated Thrombotic Microangiopathy (TA-TMA). a Single Center Experience

Alan P Skarbnik, MD, Mary E Dilorenzo, APN, Michele Simone, APN, Scott D. Rowley, MD, David H. Vesole, MD PhD, Maribel Pereiras, Pharm D, Tracy Andrews, MSc, Andrew L. Pecora, MD, Michele L. Donato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3383.
DOI: https://doi.org/10.1182/blood-2018-99-113639
Published: 2018
Journal Articles

Influence of the Gut Microbiome on Clinical Outcomes in the CPIT-001 Trial, a Phase Ib-IIA Study of Combined Checkpoint Inhibition with Nivolumab and Ipilimumab after Autologous Hematopoietic Stem Cell Transplantation in Patients at High-Risk for Post-Transplant Recurrence

Rena Feinman, PhD, Tracy Andrews, MSc, Iriana Colorado, MSc, Joshua Zenreich, Suzanne Kosky, BS, Themba Nyirenda, PhD, Noa Biran, MD, David S Siegel, MD PhD, David H. Vesole, MD PhD, Michele L. Donato, MD, Scott D. Rowley, MD, Pashna N. Munshi, MD, Michael B Atkins, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Andre Goy, MD, Robert Korngold, PhD, Alan P Skarbnik, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3443.
DOI: https://doi.org/10.1182/blood-2018-99-117669
Published: 2018
Journal Articles

Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematological Malignancies — CPIT-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Robert Korngold, PhD, Rena Feinman, PhD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD PhD, Pashna N. Munshi, MD, David S Siegel, MD PhD, Tatyana A. Feldman, MD, Noa Biran, MD, Lori A. Leslie, MD, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 256.
DOI: https://doi.org/10.1182/blood-2018-99-113586
Published: 2018
Journal Articles

Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients

Anthony R. Mato, MD MSCE, Lindsey E. Roeker, MD, Toby A. Eyre, Chadi Nabhan, MD, Nicole Lamanna, MD, Brian T. Hill, MD PhD, Danielle M. Brander, MD, Paul Barr, MD, Frederick Lansigan, MD, Bruce Cheson, MD, Arun K Singavi, MD, Maryam Yazdy, MD, Nirav N Shah, MD, John N. Allan, MD, Erica B Bhavsar, BS, Joanna Rhodes, MD, Kaitlin Kennard, RN, BSN, Stephen J. Schuster, MD, Annalynn M Williams, MS, Alan P Skarbnik, MD, Andre Goy, MD, Catherine C. Coombs, MD, Hande H. Tuncer, MD, Chaitra S. Ujjani, MD, Ryan Jacobs, MD, Allison M. Winter, MD, John M. Pagel, MD PhD, Neil Bailey, MSc, Anna Schuh, MD PhD, Mazyar Shadman, MD MPH, Andrea Sitlinger, MD, Hanna Weissbrot, BS, Sivraj Muralikrishnan, MD, Amy A Kirkwood, MSc, Christopher P. Fox, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3142.
DOI: https://doi.org/10.1182/blood-2018-99-114840
Published: 2018
Journal Articles

Applicability of the Chronic Lymphocytic Leukemia (CLL)-IPI on Patients Treated with Front-Line Ibrutinib in the Real World: The Case for New Prognostic Models

Danielle M. Brander, MD, Joanna Rhodes, MD, John M. Pagel, MD PhD, Chadi Nabhan, MD MBA, FACP, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Brian T. Hill, MD PhD, Nicole Lamanna, MD, Frederick Lansigan, MD, Mazyar Shadman, MD, Chaitra S. Ujjani, MD, Alan P Skarbnik, MD, Bruce D. Cheson, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Paul M. Barr, MD, John N. Allan, MD, Douglas F. Beach, MD, Bhavisha Patel, MD, Peter V. Pickens, MD, Sunita Dwivedy Nasta, MD, Kaitlin Kennard, RN, BSN, Hande H. Tuncer, MD, Brittany Koch, MPH, Richard R. Furman, MD, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1719.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.1719.1719
Published: 2017
Journal Articles

Phase Ib-II Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell Lymphoma

Andre Goy, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Rima Panchal Panchal, Intern, Themba Nyirenda, PhD, Alan P Skarbnik, MD, Kara Yannotti, BSN, Joshua Zenreich, Colleen M Bejot, APN, Susan Stives, APN, Kar Fai Chow, MD, Pritish K. Bhattacharyya, MD, Xiao Yang, Ernest Richards, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2785.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.2785.2785
Published: 2017
Journal Articles

Front-Line Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) in the Real World: Responses, Toxicity, Outcomes and Subsequent Therapies

Anthony R. Mato, MD, John N. Allan, MD, John M. Pagel, MD PhD, Danielle M. Brander, MD, Brian T. Hill, MD PhD, Bruce D. Cheson, MD, Richard R. Furman, MD, Nicole Lamanna, MD, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Ryan Jacobs, MD, Frederick Lansigan, MD, Paul M. Barr, MD, Mazyar Shadman, MD, Alan P Skarbnik, MD, Douglas F. Beach, MD, Jeffrey J. Pu, MD PhD, Alison R. Sehgal, MD, Allison M. Winter, MD, Clive S Zent, MD, Hande H. Tuncer, MD, Arun K Singavi, MD, Stephen J. Schuster, MD, Peter V. Pickens, MD, Nirav N Shah, MD, Annalynn Williams, MS, Christina Howlett, PharmD, BCOP, Hanna Weissbrot, BS, Naveed Ali, MD, Bhavisha Patel, MD, Krista Isaac, DO, MS, Joanna Rhodes, MD, Mitchell E. Hughes, PharmD, BCPS, BCOP, Sirin Khajavian, MD, Elizabeth T Chatburn, BS, Andrea Sitlinger, MD, Eve Tranchito, BS, Erica Bharat Bhavsar, BS, Neil Bailey, MS, Timothy F. Burns, MD, Melissa Yacur, MD, Mansi Malhotra, BS, Sasanka Handunnetti, MD, Kaitlin Kennard, RN, BSN, Chadi Nabhan, MD MBA, FACP, Chaitra S. Ujjani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3011.
DOI: https://doi.org/10.1182/blood.V130.Suppl_1.3011.3011
Published: 2017